The status of invasive pneumococcal disease among children younger than 5 years of age in north-west Lombardy, Italy

BMC Infectious Diseases, 05/08/2012

The inclusion of the 13–valent pneumococcal conjugate vaccine in immunization programs of young children might be considered to reduce incidence and morbidity of invasive pneumococcal disease in this surveilled population.

Print Article Summary Cat 2 CME Report